I am a researcher at Oslo University Hospital and the University of Oslo, where I work with economic evaluations alongside clinical trials and model-based cost-effectiveness analyses. Previously, I worked on technology assessments of new pharmaceuticals at the Norwegian Medicines Agency. I have a particular interest in uncertainty quantification and value of information methods for survival data. In my PhD project, I worked with developing new methods for quantifying the value of collecting survival data with longer follow-up, particularly aimed at the context of cancer technology appraisals informed by immature survival data.